[1]李永鸿.玉屏风散加味治疗小儿反复呼吸道感染43例[J].西部中医药,2013,26(06):60-61.
　LI Yonghong.Modified YuPingFeng San in Treating 43 Cases of Recurrent Respiratory Tract Infection in Children[J].Western Journal of Traditional Chinese Medicine,2013,26(06):60-61.
点击复制

玉屏风散加味治疗小儿反复呼吸道感染43例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年06期
页码:
60-61
栏目:
出版日期:
2013-06-15

文章信息/Info

Title:
Modified YuPingFeng San in Treating 43 Cases of Recurrent Respiratory Tract Infection in Children
文章编号:
1004-6852(2013)06-0060-02
作者:
李永鸿
武威市妇幼保健院，甘肃 武威 733000
Author(s):
LI Yonghong
Wuwei Municipal Maternal and Child Care Service Center, Wuwei 733000, China
关键词:
呼吸道感染; 玉屏风散; 疗效观察
Keywords:
respiratory tract infection;  YuPingFeng San;  clinical observation
分类号:
R473.9
文献标志码:
B
摘要:
目的：观察玉屏风散加味治疗小儿反复呼吸道感染的临床疗效。方法：将86例呼吸道感染小儿患者随机分为观察组43例和对照组43例，对照组给予利巴韦林、青霉素等常规西医治疗，观察组给予玉屏风散加味治疗，观察2组患者的治疗效果、起效时间及不良反应发生率。结果：对照组治疗总有效率略高于观察组，平均起效时间早于观察组，但无统计学意义（P＞0.05）；观察组不良反应发生率显著低于对照组（P＜0.05）。结论：玉屏风散加味治疗小儿呼吸道感染的临床疗效与西医治疗相近，起效时间差别不大，但观察组毒副作用明显减少。
Abstract:
Objective: To discuss clinical effects of modified YuPingFeng San in treating recurrent respiratory tract infection. Method: All 86 patients were randomized into 43 cases of the observation group and 43 cases of the control group, the control group received routine treatment including ribavirin, penicillin and others, and the observation group took modified YuPingFeng San, clinical effects, onset time and the incidence of adverse reaction of patients in both groups were observed. Result: Total effective rate of the control group was slightly higher than that of the observation group, average onset time was earlier than that of the observation group, but it had no statistical meaning (P＞0.05); the incidence of adverse reaction of the observation group was lower than that of the control group remarkably (P＜0.05). Conclusion: Clinical effects of modified YuPingFeng San in treating recurrent respiratory tract infection are similar to the western medicine, there is no big difference in onset time, but side effects of the observation group lessen.

相似文献/References:

[1]李雪嫣,张李峰,桂曼曼,等.复方玉屏风散对小鼠细胞免疫力的增强作用研究[J].西部中医药,2013,26(08):11.
　LI Xueyan,ZHANG Lifeng,GUI Manman,et al.Study on Compound YuPingFengSan Oral Liquid Improving Cellular Immunity of Mice[J].Western Journal of Traditional Chinese Medicine,2013,26(06):11.
[2]刘麒.玉屏风散合桂枝汤治疗肺卫不固型自汗43例[J].西部中医药,2015,28(06):98.[doi:2015/6/16 0:00:00]
[3]胡静雪,师建国.艾灸联合玉屏风散治疗小儿脾胃虚弱型泄泻38例[J].西部中医药,2017,30(02):84.
　Moxa with YuPingFeng San in Treating 8 Cases of Infantile Diarrhea of Weakness of the Spleen and Stomach.Moxa with YuPingFeng San in Treating 38 Cases of Infantile Diarrhea of Weakness of the Spleen and Stomach[J].Western Journal of Traditional Chinese Medicine,2017,30(06):84.
[4]沈玉鹏,任耀全,李冬梅,等.穴位贴敷联合中药辨证治疗对反复呼吸道感染患儿免疫及微量元素的影响[J].西部中医药,2016,29(05):96.
　SHEN Yupeng,REN Yaoquan,LI Dongmei,et al.The Influence of Acupoint Application Combined with Syndrome Differentiation and Herbs on the Immunity and Trace Elements of the Children with Recurrent Respiratory Tract Infection[J].Western Journal of Traditional Chinese Medicine,2016,29(06):96.
[5]平静,王思源,董丹,等.双表法对流感病毒感染小鼠肺组织TLR4/NF-κB信号通路的调控作用[J].西部中医药,2020,33(05):18.[doi:10.12174/j.issn.1004-6852.2020.05.05]
　PING Jing,WANG Siyuan,DONG Dan,et al.The Regulatory Effects of Double Exterior Method on TLR4/NF-κB Signal Path of Lung Tissue in Influenza Virus-infected Mice[J].Western Journal of Traditional Chinese Medicine,2020,33(06):18.[doi:10.12174/j.issn.1004-6852.2020.05.05]
[6]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(06):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[7]方识进.中西医结合治疗甲型H1N1流感病毒性小儿呼吸道感染的临床疗效[J].西部中医药,2021,34(12):112.[doi:10.12174/j.issn.2096-9600.2021.12.30]
　FANG Shijin.Clinical Effects of Integrative Medicine in Treating Respiratory Tract Infection in Children Caused by Influenza A (H1N1) Virus[J].Western Journal of Traditional Chinese Medicine,2021,34(06):112.[doi:10.12174/j.issn.2096-9600.2021.12.30]
[8]王登,王娣,曹青,等.基于ACE2受体探讨玉屏风散预防新型冠状病毒肺炎的网络药理学机制[J].西部中医药,2023,36(02):18.[doi:10.12174/j.issn.2096-9600.2023.02.04]
　WANG Deng,WANG Di,CAO Qing,et al.Network Pharmacology Mechanism of Yupingfeng Powder for the Prevention of COVID-19 Based on ACE2 Receptor[J].Western Journal of Traditional Chinese Medicine,2023,36(06):18.[doi:10.12174/j.issn.2096-9600.2023.02.04]

备注/Memo

备注/Memo:
收稿日期：2013-01-28 作者简介：李永鸿(1967—)，女，主治医师。研究方向：儿科常见病的诊治。
更新日期/Last Update: 2013-06-15